Notice Number: NOT-DK-07-002
Release Date: January 23, 2007
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) (http://www.niddk.nih.gov)
The National Institute of Diabetes and Digestive Diseases (NIDDK) announces the termination of the PA-06-176: Insulin Signalling and Receptor Cross-Talk (R21).
New or revised applications will NOT be accepted for the above reference PA after January 23, 2007.
The NIDDK is participating in the NIH Exploratory/Developmental Research Grant Program (Parent R21) which may found at http://grants.nih.gov/grants/guide/pa-files/PA-06-181.html. Information about NIDDK’s R21 program can be found at http://www2.niddk.nih.gov/Funding/Grants/ApplicantGuidelines/R21.htm . Applicants with research interest in areas important to the NIDDK mission, who are considering applying to the Parent R21 announcement, are encouraged to consult with NIDDK Program Staff before submitting an application.
For questions regarding research areas important to the mission of NIDDK please contact:
For Diabetes, Endocrinology, and Metabolic Diseases:
Catherine McKeon, Ph.D.
6707 Democracy Boulevard, Room 6103
Bethesda, MD 20892-5460
Telephone: (301) 594-8810
FAX: (301) 480-3503
For Digestive Diseases, Obesity, and Nutrition:
Robert Karp, Ph.D.
6707 Democracy Boulevard, Room 671
Bethesda, MD 20892-5450
FAX: (301) 480-8300
For Kidney and Urologic Disorders:
Christian Ketchum, Ph.D.
6707 Democracy Boulevard, Room 647
Bethesda, MD 20892-5458
Telephone: (301) 594-7717
FAX: (301) 480-3510
Weekly TOC for this Announcement
NIH Funding Opportunities and Notices
Office of Extramural
National Institutes of Health (NIH)
9000 Rockville Pike
Bethesda, Maryland 20892
Department of Health
and Human Services (HHS)